May 30, 2023 ILPA releases new continuation fund guidance By Isabel Dische Robert Schmidt The Institutional Limited Partners Association (ILPA) recently announced new guidance regarding the formation and offering of...
May 26, 2023 The Chancellor unveils £650 million package to drive growth in British life sciences By David Dowling Jeremy Hunt, the Chancellor, has this week revealed his ‘Life Sci for Growth’. Consisting of a multi-prong approach, it follows the...
May 25, 2023 From likes to strikes: the implications of the record-breaking €1.2 billion GDPR fine By Christopher Foo On 22 May 2023, the Irish data protection regulator (DPC) announced that it had issued a record-breaking €1.2 billion fine in a decision...
May 25, 2023 The one with the snazzy compliance training videos By Nitish Upadhyaya Hui Chen The Wall Street Journal reported last week that Microsoft employees are hooked on a series of compliance training videos. Blockbuster...
May 25, 2023 A new regulatory regime for the UK’s digital economy By Dervla Broderick Ruchit Patel On 25 April 2023, the UK’s much anticipated Digital Markets, Competition and Consumers Bill (the Bill) was published. The Bill has three...
May 24, 2023 ICO publishes new guidance on responding to subject access requests By Ropes & Gray The right of subject access has long been regarded as critical in ensuring that organisations that collect and use individuals' personal...
May 23, 2023 Sanctions evasion guidance for high value dealers and art market participants By Paige Berges The UK’s Office of Financial Sanctions Implementation (OFSI) released guidance aimed to help “high value dealers” and art market...
May 23, 2023 Why start-ups and venture funds need to take note of the Labour Party By David Dowling Labour Shadow Chancellor, Rachel Reeves, is using a trip to the US to continue the Labour Party’s push to be seen as the party of...
May 22, 2023 Financial services: banking on AI? By Edward Machin Last week I had the pleasure of speaking on a panel at the NICE Actimize conference in London, where we explored the applications,...
May 19, 2023 Why pharma should pay attention to the Labour Party’s plans for the NHS and clinical trials By David Dowling Sophie Waters In the wake of the Conservative Party’s bruising local election results, there is a continued focus on what a Labour-led Government might...
May 17, 2023 Relaunch of the EMA’s policy on the proactive publication of clinical data By Lincoln Tsang Hannah Kerr-Peterson In September 2023, the European Medicines Agency (EMA) will reinstate Policy 0070 (the Policy), pursuant to which clinical data submitted...
May 16, 2023 PE-backed possible offers driving uptick in UK takeover activity By Angela Becker Helen Croke Shona Ha Victoria McGrath John Newton Dan Oates Alexander Robb Simon Saitowitz Elizabeth Todd +6 more... Show less Although 2022 was a comparatively quiet year for private equity-backed takeovers of UK-listed companies, 2023 has seen an uptick in...
May 16, 2023 UK's NCSC and ICO encourage greater transparency around cyber attacks By Ropes & Gray It seems that cyber attacks, particularly through the use of ransomware, continue to pose a serious threat to UK businesses. It was...
May 15, 2023 Call of Duty: The proposed reform of UK stamp taxes on shares By Benjamin Wonnacott Gemma Dowling HMRC’s recently-launched Stamp Taxes on Shares modernisation consultation gives welcome new impetus to the much-needed reform of the UK...
May 15, 2023 Further details revealed regarding the EU’s proposed 11th package of sanctions against Russia By Kevin Nordin Sienna Hewavidana On May 9, 2023, in a press statement with Ukrainian President Volodymyr Zelenskyy, President of the European Commission, Ursula von der...
May 11, 2023 Controversy around the UK's Online Safety Bill continues By Ropes & Gray The debate concerning the UK's controversial Online Safety Bill (OSB) has continued to rumble on in recent days, with the UK Government...